Table 3.
Prescribing pattern of proton pump inhibitors (PPIs) at 3 and 12 months postrofecoxib withdrawal
| NSAID group | Number (%)*initiating PPIs (3 months) | Number (%)*continuing PPIs (3 months) | Number (%)*initiating PPIs (12 months) | Number (%)*continuing PPIs (12 months) |
|---|---|---|---|---|
| None | 41 (4.3) | 360 (59.4) | 67 (12.5) | 248 (64.1) |
| Non-selective (excl. nimesulide) | 57 (9.0) | 326 (81.5) | 150 (21.7) | 360 (87.4) |
| Other COX-2 inhibitor | 48 (5.9) | 503 (79.2) | 63 (16.8) | 237 (91.5) |
| Nimesulide | 16 (6.6) | 151 (79.5) | 37 (16.9) | 160 (88.9) |
| Sequential NSAIDs | 47 (12.9) | 235 (74.8) | 319 (26.8) | 786 (86.7) |
| χ2P-value | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
*
Percentages based on figures for each subgroup in Table 2